Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos

Detalhes bibliográficos
Autor(a) principal: Menezes, Elizabeth Gomes Paulino
Data de Publicação: 2009
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFG
Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tede/3581
Resumo: In this study the antileukemic potential of grandisin, a neolignan extracted from Piper solmsianum, was investigated against K-562 lymphocytic genealogy, which demonstrates a phenotype of resistance to new drugs. The cytotoxicity of grandisin (0.018 to 2.365 μMol) was evaluated in K-562 and in normal peripheral blood lymphocytes by using Blue of Trypan and MTT({[3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium] bromide}) methods. In the cytotoxic activity research about grandisin on K-562 cells and lymphocytes during 24 hours by the Blue of Trypan method, the grandisin got IC50 (inhibitory concentration to fifty percent) of 1.075 and 0.375 μMol to lymphocytes and K-562, respectively. After 48 hours, the cytotoxicity in normal cells remained themselves and we noticed there was an increase in IC50 leukemic cells of 0.198 μMol and 0.200 μMol in K-562 and lymphocytes, respectively. For the MTT test, results were similar to those found during the previous experiment (IC50K-562 11,98 μMol IC50lymphocytes 0,425 μMol for a period of 24 hours and IC50K-562 0,685 IC50lymphocytes 0,851 μMol for a period of 48 hours). The research about cell death mechanisms showed the treatment in K-562 cells joined to 0.036 μMol of grandisin during 24 hours, induces to an increase of cells population in G1 stage of cell cycle and it also induces to a decline of cells population in G2 stage and S, respectively. These factors also indicate that the grandisin was induced to a cell cycle standstill in G1 stage, which is proportionated to the most antileukemic agents existing. Cell death with apoptosis signs was showed by the research about these cells morphology. Moreover, the treatment of leukemic cells with 0.072, 0.036, 0.018 μMol of grandisin during 24 hours has promoted exposure of annexin V, wich is a first indicator of apoptosis. In these cells, the activity research of 3, 6 and 9 caspases and cell death mediators Bcl2 and Bax showed that cell death happens in dependent-caspase way and with balance induction between Bcl2 and Bax. Collectively, these results introduce a new model able to induce apoptosis in a leukemic cell genealogy with important features of resistance to the process of programmed cell death.
id UFG-2_aedb629fdd705e98c80df7df2292e2ef
oai_identifier_str oai:repositorio.bc.ufg.br:tede/3581
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
repository_id_str
spelling Bozinis, Marize Campos Valadareshttp://lattes.cnpq.br/6157755243167018Bozinis, Marize Campos ValadaresPessoa, Cláudia de ÓRibeiro, Elisângelahttp://lattes.cnpq.br/9297937588040111Menezes, Elizabeth Gomes Paulino2014-11-10T15:39:56Z2009-11-03MENEZES, Elizabeth Gomes Paulino. Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos. 2009. 85 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Goiás, Goiânia, 2009.http://repositorio.bc.ufg.br/tede/handle/tede/3581In this study the antileukemic potential of grandisin, a neolignan extracted from Piper solmsianum, was investigated against K-562 lymphocytic genealogy, which demonstrates a phenotype of resistance to new drugs. The cytotoxicity of grandisin (0.018 to 2.365 μMol) was evaluated in K-562 and in normal peripheral blood lymphocytes by using Blue of Trypan and MTT({[3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium] bromide}) methods. In the cytotoxic activity research about grandisin on K-562 cells and lymphocytes during 24 hours by the Blue of Trypan method, the grandisin got IC50 (inhibitory concentration to fifty percent) of 1.075 and 0.375 μMol to lymphocytes and K-562, respectively. After 48 hours, the cytotoxicity in normal cells remained themselves and we noticed there was an increase in IC50 leukemic cells of 0.198 μMol and 0.200 μMol in K-562 and lymphocytes, respectively. For the MTT test, results were similar to those found during the previous experiment (IC50K-562 11,98 μMol IC50lymphocytes 0,425 μMol for a period of 24 hours and IC50K-562 0,685 IC50lymphocytes 0,851 μMol for a period of 48 hours). The research about cell death mechanisms showed the treatment in K-562 cells joined to 0.036 μMol of grandisin during 24 hours, induces to an increase of cells population in G1 stage of cell cycle and it also induces to a decline of cells population in G2 stage and S, respectively. These factors also indicate that the grandisin was induced to a cell cycle standstill in G1 stage, which is proportionated to the most antileukemic agents existing. Cell death with apoptosis signs was showed by the research about these cells morphology. Moreover, the treatment of leukemic cells with 0.072, 0.036, 0.018 μMol of grandisin during 24 hours has promoted exposure of annexin V, wich is a first indicator of apoptosis. In these cells, the activity research of 3, 6 and 9 caspases and cell death mediators Bcl2 and Bax showed that cell death happens in dependent-caspase way and with balance induction between Bcl2 and Bax. Collectively, these results introduce a new model able to induce apoptosis in a leukemic cell genealogy with important features of resistance to the process of programmed cell death.Neste estudo, o potencial antileucêmico da grandisina, uma neolignana extraída de Piper solmsianum, foi investigado contra a linhagem leucêmica K-562, a qual apresenta fenótipo de resistência a fármacos. A citotoxicidade da grandisina (0,018 – 2,365 μMol) foi avaliada em K-562 e em linfócitos do sangue periférico normal utilizando os métodos de Azul de Tripano e MTT({brometo de [3-(4,5-dimetiltiazol-2-yl)-2,5-difeniltetrazolio]}). Na investigação da atividade citotóxica da grandisina sobre células K-562 e linfócitos por 24 horas pelo método azul de tripano, a grandisina apresentou IC50 (concentração inibitória para cinqüenta porcento) de 1,075 μMol e 0,375 μMol para linfócitos e K-562, respectivamente. Após 48 horas a citotoxicidade para as células normais se manteve e observamos aumento para as células leucêmicas IC50 0,198 μMol e 0,200 μMol para K-562 e linfócitos, respectivamente. Para o teste de MTT os resultados foram semelhantes aos encontrados no ensaio anterior (IC50K-562 11,98 μMol IC50linfócitos 0,425 μMol para 24 horas e IC50K-562 0,685 μMol IC50linfócitos 0,851 μMol para 48 horas ). A investigação dos mecanismos de morte celular demonstrou que o tratamento das células K-562 com 0,036 μMol de grandisina por 24 horas induz ao aumento da população de células em fase G1 do ciclo celular e uma diminuição da população de células em fase G2 e S, respectivamente, indicando que a grandisina induziu parada do ciclo celular em fase G1, o que condiz com a maioria dos antileucêmicos existentes. A investigação da morfologia destas células indicou morte celular com sinais de apoptose. Além disto, o tratamento das células leucêmicas com 0,072, 0,036, 0, 018 μMol de grandisina por 24 horas promoveu a externalização da anexina V, um indicador primário de apoptose. Nestas células, a investigação da atividade das caspases 6, 8 e 9 e dos mediadores do processo de morte celular Bcl2 e Bax demonstrou que a morte celular ocorre via caspase-dependente e com indução de modulação entre Bcl2 e Bax. Coletivamente estes resultados introduzem um novo modelo capaz de induzir apoptose em uma linhagem celular leucêmica com importantes características de resistência ao processo de morte celular programada.Submitted by Erika Demachki (erikademachki@gmail.com) on 2014-11-10T15:39:39Z No. of bitstreams: 2 Dissertação - Elizabeth Gomes Paulino Menezes - 2009.pdf: 1425255 bytes, checksum: 6aa32c741dbfa1d3e72e004f919b5326 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Approved for entry into archive by Erika Demachki (erikademachki@gmail.com) on 2014-11-10T15:39:55Z (GMT) No. of bitstreams: 2 Dissertação - Elizabeth Gomes Paulino Menezes - 2009.pdf: 1425255 bytes, checksum: 6aa32c741dbfa1d3e72e004f919b5326 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Made available in DSpace on 2014-11-10T15:39:56Z (GMT). No. of bitstreams: 2 Dissertação - Elizabeth Gomes Paulino Menezes - 2009.pdf: 1425255 bytes, checksum: 6aa32c741dbfa1d3e72e004f919b5326 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2009-11-03application/pdfhttp://repositorio.bc.ufg.br/tede/retrieve/12068/Disserta%c3%a7%c3%a3o%20-%20Elizabeth%20Gomes%20Paulino%20Menezes%20-%202009.pdf.jpgporUniversidade Federal de GoiásPrograma de Pós-graduação em Ciências Farmacêuticas (FF)UFGBrasilFaculdade Farmácia - FF (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessGrandisinaCitotoxicidadeApoptoseK-562GrandisinCytotoxicityApoptosisFARMACIA::ANALISE E CONTROLE E MEDICAMENTOSAvaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis82493698819615241260060060060102811615242093756216025074656932336reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/cf519ae7-adcc-4040-9767-cee9ff65061f/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/744bfb10-b187-4701-ae03-bb31e4d73f3a/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-822302http://repositorio.bc.ufg.br/tede/bitstreams/622c3671-292f-4f1e-a3a7-17ab4be8e0dd/download1e0094e9d8adcf16b18effef4ce7ed83MD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-823148http://repositorio.bc.ufg.br/tede/bitstreams/45dc2afe-ea65-405c-a6b5-16c915e94690/download9da0b6dfac957114c6a7714714b86306MD54ORIGINALDissertação - Elizabeth Gomes Paulino Menezes - 2009.pdfDissertação - Elizabeth Gomes Paulino Menezes - 2009.pdfapplication/pdf1425255http://repositorio.bc.ufg.br/tede/bitstreams/7de261e2-820b-47e7-b9d6-c804cbfa8141/download6aa32c741dbfa1d3e72e004f919b5326MD55TEXTDissertação - Elizabeth Gomes Paulino Menezes - 2009.pdf.txtDissertação - Elizabeth Gomes Paulino Menezes - 2009.pdf.txtExtracted Texttext/plain144531http://repositorio.bc.ufg.br/tede/bitstreams/b2edf68f-49b2-4c4d-8176-4a5b1ee88226/download9282515c06c83648f8a92c43ada173d4MD56THUMBNAILDissertação - Elizabeth Gomes Paulino Menezes - 2009.pdf.jpgDissertação - Elizabeth Gomes Paulino Menezes - 2009.pdf.jpgGenerated Thumbnailimage/jpeg1943http://repositorio.bc.ufg.br/tede/bitstreams/c048b9db-eeb7-466f-bd8d-247a20bc2395/downloadcc73c4c239a4c332d642ba1e7c7a9fb2MD57tede/35812014-11-11 03:02:39.27http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/3581http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2014-11-11T05:02:39Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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
dc.title.por.fl_str_mv Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos
title Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos
spellingShingle Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos
Menezes, Elizabeth Gomes Paulino
Grandisina
Citotoxicidade
Apoptose
K-562
Grandisin
Cytotoxicity
Apoptosis
FARMACIA::ANALISE E CONTROLE E MEDICAMENTOS
title_short Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos
title_full Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos
title_fullStr Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos
title_full_unstemmed Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos
title_sort Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos
author Menezes, Elizabeth Gomes Paulino
author_facet Menezes, Elizabeth Gomes Paulino
author_role author
dc.contributor.advisor1.fl_str_mv Bozinis, Marize Campos Valadares
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/6157755243167018
dc.contributor.referee1.fl_str_mv Bozinis, Marize Campos Valadares
dc.contributor.referee2.fl_str_mv Pessoa, Cláudia de Ó
dc.contributor.referee3.fl_str_mv Ribeiro, Elisângela
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/9297937588040111
dc.contributor.author.fl_str_mv Menezes, Elizabeth Gomes Paulino
contributor_str_mv Bozinis, Marize Campos Valadares
Bozinis, Marize Campos Valadares
Pessoa, Cláudia de Ó
Ribeiro, Elisângela
dc.subject.por.fl_str_mv Grandisina
Citotoxicidade
Apoptose
K-562
topic Grandisina
Citotoxicidade
Apoptose
K-562
Grandisin
Cytotoxicity
Apoptosis
FARMACIA::ANALISE E CONTROLE E MEDICAMENTOS
dc.subject.eng.fl_str_mv Grandisin
Cytotoxicity
Apoptosis
dc.subject.cnpq.fl_str_mv FARMACIA::ANALISE E CONTROLE E MEDICAMENTOS
description In this study the antileukemic potential of grandisin, a neolignan extracted from Piper solmsianum, was investigated against K-562 lymphocytic genealogy, which demonstrates a phenotype of resistance to new drugs. The cytotoxicity of grandisin (0.018 to 2.365 μMol) was evaluated in K-562 and in normal peripheral blood lymphocytes by using Blue of Trypan and MTT({[3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium] bromide}) methods. In the cytotoxic activity research about grandisin on K-562 cells and lymphocytes during 24 hours by the Blue of Trypan method, the grandisin got IC50 (inhibitory concentration to fifty percent) of 1.075 and 0.375 μMol to lymphocytes and K-562, respectively. After 48 hours, the cytotoxicity in normal cells remained themselves and we noticed there was an increase in IC50 leukemic cells of 0.198 μMol and 0.200 μMol in K-562 and lymphocytes, respectively. For the MTT test, results were similar to those found during the previous experiment (IC50K-562 11,98 μMol IC50lymphocytes 0,425 μMol for a period of 24 hours and IC50K-562 0,685 IC50lymphocytes 0,851 μMol for a period of 48 hours). The research about cell death mechanisms showed the treatment in K-562 cells joined to 0.036 μMol of grandisin during 24 hours, induces to an increase of cells population in G1 stage of cell cycle and it also induces to a decline of cells population in G2 stage and S, respectively. These factors also indicate that the grandisin was induced to a cell cycle standstill in G1 stage, which is proportionated to the most antileukemic agents existing. Cell death with apoptosis signs was showed by the research about these cells morphology. Moreover, the treatment of leukemic cells with 0.072, 0.036, 0.018 μMol of grandisin during 24 hours has promoted exposure of annexin V, wich is a first indicator of apoptosis. In these cells, the activity research of 3, 6 and 9 caspases and cell death mediators Bcl2 and Bax showed that cell death happens in dependent-caspase way and with balance induction between Bcl2 and Bax. Collectively, these results introduce a new model able to induce apoptosis in a leukemic cell genealogy with important features of resistance to the process of programmed cell death.
publishDate 2009
dc.date.issued.fl_str_mv 2009-11-03
dc.date.accessioned.fl_str_mv 2014-11-10T15:39:56Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv MENEZES, Elizabeth Gomes Paulino. Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos. 2009. 85 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Goiás, Goiânia, 2009.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tede/3581
identifier_str_mv MENEZES, Elizabeth Gomes Paulino. Avaliação da atividade citotóxica e indutora de apoptose da grandisina em células leucêmicas K-562 com fenótipo de resistência a fármacos. 2009. 85 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Goiás, Goiânia, 2009.
url http://repositorio.bc.ufg.br/tede/handle/tede/3581
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 824936988196152412
dc.relation.confidence.fl_str_mv 600
600
600
dc.relation.department.fl_str_mv 6010281161524209375
dc.relation.cnpq.fl_str_mv 6216025074656932336
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Ciências Farmacêuticas (FF)
dc.publisher.initials.fl_str_mv UFG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade Farmácia - FF (RG)
publisher.none.fl_str_mv Universidade Federal de Goiás
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
instname_str Universidade Federal de Goiás (UFG)
instacron_str UFG
institution UFG
reponame_str Repositório Institucional da UFG
collection Repositório Institucional da UFG
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/cf519ae7-adcc-4040-9767-cee9ff65061f/download
http://repositorio.bc.ufg.br/tede/bitstreams/744bfb10-b187-4701-ae03-bb31e4d73f3a/download
http://repositorio.bc.ufg.br/tede/bitstreams/622c3671-292f-4f1e-a3a7-17ab4be8e0dd/download
http://repositorio.bc.ufg.br/tede/bitstreams/45dc2afe-ea65-405c-a6b5-16c915e94690/download
http://repositorio.bc.ufg.br/tede/bitstreams/7de261e2-820b-47e7-b9d6-c804cbfa8141/download
http://repositorio.bc.ufg.br/tede/bitstreams/b2edf68f-49b2-4c4d-8176-4a5b1ee88226/download
http://repositorio.bc.ufg.br/tede/bitstreams/c048b9db-eeb7-466f-bd8d-247a20bc2395/download
bitstream.checksum.fl_str_mv bd3efa91386c1718a7f26a329fdcb468
4afdbb8c545fd630ea7db775da747b2f
1e0094e9d8adcf16b18effef4ce7ed83
9da0b6dfac957114c6a7714714b86306
6aa32c741dbfa1d3e72e004f919b5326
9282515c06c83648f8a92c43ada173d4
cc73c4c239a4c332d642ba1e7c7a9fb2
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository.mail.fl_str_mv tasesdissertacoes.bc@ufg.br
_version_ 1798044426522591232